Form 4: STERIS plc Executive Sells Shares After Option Exercise
SEC Form 4 Filing
Cary L. Majors, SVP and President, Healthcare at STERIS plc, exercised stock options and sold shares on May 20, 2025.
Summary
- On May 20, 2025, Cary L. Majors, SVP and President, Healthcare at STERIS plc, exercised employee stock options to acquire 12,828 ordinary shares at a price of $147.05 per share.
- Majors then sold 8,247 shares at a weighted average price of $249.73 and 4,581 shares at a weighted average price of $250.71.
- Following these transactions, Majors directly owns 11,372 ordinary shares, with an additional 67 shares held indirectly through the STERIS Corporation 401(k) Plan.
- 9,872 of the directly owned shares are restricted and will vest at various dates in the future.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock transactions. It doesn't contain information that would strongly suggest a positive or negative outlook for the company.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for executives who receive stock options as part of their compensation. The sale of shares may be for personal financial planning reasons and doesn't necessarily reflect a negative outlook on the company.
Comparison to Industry Standards
- Executive compensation packages in the medical device and healthcare industry often include stock options to align management's interests with those of shareholders.
- The vesting schedules for restricted shares are typical, designed to incentivize long-term commitment to the company.
- Comparing the exercise price and sale price to those of peers such as Medtronic or Boston Scientific would provide further context on the profitability of these options.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, but it is a common practice and doesn't necessarily indicate a problem with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date of earliest transaction: Exercise of stock options and sale of shares. |
| 05/22/2025 | Date of signature on the Form 4 filing. |
| 05/31/2029 | Expiration date of the employee stock option. |
| 06/02/2025 | 1,964 restricted ordinary shares lapse. |
| 10/01/2025 | 692 restricted ordinary shares lapse. |
| 06/01/2026 | 2,697 restricted ordinary shares lapse. |
| 06/02/2026 | 2,140 restricted ordinary shares lapse. |
| 06/04/2027 | 2,379 restricted ordinary shares lapse. |
Keywords
STERIS plc, Cary L. Majors, stock options, share sale, Form 4, insider trading, executive compensation, ordinary shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.